These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 25158579

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Hypercalcemia].
    Ziegler R.
    Ther Umsch; 2000 Jun; 57(6):391-7. PubMed ID: 10894025
    [Abstract] [Full Text] [Related]

  • 23. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S, Tisell LE, Lindstedt G, Lundberg PA.
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Iatrogenic hypercalcemia].
    Akatsu T.
    Nihon Rinsho; 2006 Jun 28; Suppl 2():165-8. PubMed ID: 16817375
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical practice. Asymptomatic primary hyperparathyroidism.
    Bilezikian JP, Silverberg SJ.
    N Engl J Med; 2004 Apr 22; 350(17):1746-51. PubMed ID: 15103001
    [No Abstract] [Full Text] [Related]

  • 29. Symptomatic hypercalcemia in the first months of life: calcium-regulating hormones and treatment.
    Ghirri P, Bottone U, Coccoli L, Bernardini M, Vuerich M, Cuttano A, Riparbelli C, Pellegrinetti G, Boldrini A.
    J Endocrinol Invest; 1999 May 22; 22(5):349-53. PubMed ID: 10401708
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Hypercalcemia is the most common manifestation of hyperparathyroidism].
    Yuzawa Y, Watanabe Y.
    Nihon Rinsho; 1995 Apr 22; 53(4):864-9. PubMed ID: 7752474
    [Abstract] [Full Text] [Related]

  • 34. The patient with hypercalcaemia.
    Heath D.
    Practitioner; 2002 Jan 22; 246(1630):44-9. PubMed ID: 11816418
    [No Abstract] [Full Text] [Related]

  • 35. Pathophysiology and management of severe hypercalcemia.
    Nussbaum SR.
    Endocrinol Metab Clin North Am; 1993 Jun 22; 22(2):343-62. PubMed ID: 8325291
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
    Han GY, Wang O, Xing XP, Meng XW, Lian XL, Guan H, Ye W, Xia WB, Li M, Jiang Y, Hu YY, Liu HC, Cui QC.
    Zhonghua Nei Ke Za Zhi; 2009 Sep 22; 48(9):729-33. PubMed ID: 20079207
    [Abstract] [Full Text] [Related]

  • 39. Hyperparathyroidism: primary or secondary disease?
    Cordellat IM.
    Reumatol Clin; 2012 Sep 22; 8(5):287-91. PubMed ID: 22089066
    [Abstract] [Full Text] [Related]

  • 40. Laboratory diagnosis of primary hyperparathyroidism.
    Marcus R.
    Endocrinol Metab Clin North Am; 1989 Sep 22; 18(3):647-58. PubMed ID: 2550219
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.